Thomson Medical (SGX:A50) booked a loss attributable to owners of the company of SG$12.9 million for the six months ended Dec. 31, 2024, against an attributable profit of SG$2.0 million a year earlier, a filing with the Singapore Exchange said on Wednesday.
Loss per share came in at SG$0.00049 compared with earnings per share of SG$0.00008 in the comparable period.
Revenue was, however, up 18% year over year to SG$199.1 million from SG$168.1 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.